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Evidence for pheomelanin sheet structure
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Melanin remains one of the most enigmatic of pigments. It occurs in a variety of forms, but is perhaps
best known for its role in providing ultra-violet protection of skin as brown/black eumelanin and red/yellow
pheomelanin. Despite decades of research many questions remain about the structure, spectroscopy and
biology of both forms. For example, their unusually broad optical absorption spectra have attracted different
explanations, no protomolecule has ever been identified and pheomelanin has been implicated in melanoma,
the most virulent form of skin cancer. Knowing more about the structure and spectroscopy of melanin is
of paramount importance, not only in biology and medicine, but also in the design of biomimetic functional
devices. There is general consistency across a variety of techniques that eumelanin’s building blocks arrange
in pi-stacked sheets analogous to graphite. By comparison pheomelanin has been the neglected sibling and
here we present evidence from fluorescence spectroscopy for pheomelanin also displaying sheet-like behavior.
As pheomelanin is synthesized the temporal response of the fluorescence intensity of the sheet-sensing probe
thioflavin T (ThT) follows a similar sigmoidal increase as previously reported for eumelanin. Consistent with
such intercalation fluorescence decay measurements reveal evidence for close coupling between melanin and
ThT excited states.
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Melanin is an important pigment found in hu-
man skin, hair, the eye and the brain and other
organisms. In skin it occurs predominantly as the
black/brown pigment eumelanin and also less frequently
in the form of red/yellow pheomelanin. In vertebrates
a complex melanogenesis pathway occurs in organelles
called melanosomes within melanocytes1 and requires
the copper-containing enzyme tyrosinase to catalyze the
oxidation of tyrosine and 3,4-dihydroxy-L-phenylalanine
(L-DOPA) to form dopaquinone, which rapidly un-
dergoes internal cyclization to form dopachrome
and subsequently 5,6-dihydroxyindole (DHI) and 5,6-
dihydroxyindole-2-carboxylic acid (DHICA) and their
oxidized forms, which together constitute eumelanin.
Pheomelanin follows a similar synthetic pathway up to
dopaquinone, but then requires the addition of cys-
teine to form the precursor cysteinldopa leading to
mainly sulfur-containing benzothiazine and benzothia-
zole derivatives1 rather than DHI and DHICA. For both
forms of melanin their broad-band absorption spectra
from the ultra-violet to the near infra-red (Figure 1(a))
is generally taken to imply they are composed of a het-
erogenic polymeric mixture of different oligomers, each
with their own spectroscopy, rather than replication of a
protomolecule.
Eumelanin is thought to provide most of the ultra-
violet protection in humans, carrying with it free radical
scavenging properties of benefit in minimizing the sus-
ceptibility to skin cancer, the most virulent of which be-
ing melanoma. By contrast pheomelanin predominates
in people with reddish hair and is thought to be im-
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plicated in producing cancer-inducing phototoxic species
such as reactive oxygen species2 and mutations.3 The
ratio of pheo- to eu-melanin has been demonstrated to
be a potential cancer biomarker using two-photon ex-
cited fluorescence,4–6 but the complexity of the approach
makes it impractical and despite considerable research,
optical biopsies have yet to replace excision in testing
for melanoma. Nevertheless the urgent need for more
practical and simpler alternatives to excision remains and
optical approaches remain at the forefront of this area.
The importance of such cancer biomarkers spans clinical
progression as it is also of relevance in improving tumor
margin estimation in optically-guided surgery.7
The coexistence of pheo- and eu-melanin and its
relevance to optical biopsy for routine screening and
cancer surgery are predicated on the need for im-
proved spectroscopic descriptions and a better under-
standing of melanin’s different structural forms. More-
over, the interest in melanin is not limited to biol-
ogy and medicine as it is spurring on new ideas in
biomimetics8,9 due to melanin’s unique combination of
physical properties.10 Here also the lack of knowledge
about melanin’s structure-spectroscopic relationship is
an impediment to progress. Even melanin’s much-
studied broad absorption spectrum, which underpins
its sun-screening properties, continues to attract dif-
ferent explanations. Early descriptions10 included that
of a semiconductor, distinct states and scattering, and
more recently excitonic coupling11 along with long-range
water-induced coulombic interaction.12 Melanin’s intrin-
sic fluorescence has so far been similarly unrevealing as it
is weak and complicated by overlapping bands,13,14 thus
offering little structural insight (Figure 1(b)).
Despite the conundrum melanin presents eumelanin’s
photophysical properties are thought to be determined
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FIG. 1. (a) Absorption spectra of eumelanin and pheomelanin at 24 hours into the synthesis. (b) The fluorescence emission
spectra of ThT (40 µM), pheomelanin (40 µM) and ThT in pheomelanin when excited at 450 nm, both pheomelanin mea-
surements at 2 hours into the synthesis. The concentration of tyrosinase used was 750 u/ml. (c) The structures of ThT and
pheomelanin’s primary benzothiazole and benzothiazine groups are shown underneath.
by redox states of DHI and DHICA arranged in a sheet
structure akin to graphite and bound by pi-pi∗ inter-
actions (∼ 0.3 – 0.4 nm apart).15,16 The evidence for
this has been found from a number of sources including
scanning electron microscopy (SEM) and atomic force
microscopy (AFM).17,18 Most importantly the manner
in which pheomelanin’s moieties are arranged is much
less well-established than for eumelanin. Perhaps some-
what surprisingly there are few reports of the use of ex-
trinsic fluorescence probes to study melanin structure.
Previously our Group obtained complementary evidence
of a sheet structure in eumelanin19 to that from SEM
and AFM by monitoring the laboratory synthesis of eu-
melanin using the fluorescence intensity of thioflavin T
(ThT), which is commonly used to monitor formation of
β-sheets of β–amyloid (Aβ) which lead to fibril forma-
tion associated with Alzheimer’s disease.20 Here we ap-
ply the same approach to the synthesis of pheomelanin
and extended it to fluorescence decay measurements for
both forms in order that we can provide a more compre-
hensive comparison with the work reported previously,
which was limited to fluorescence spectral and intensity
information.19 In contrast to the indole structure of eu-
melanin’s building blocks both ThT and pheomelanin’s
building blocks share some structural similarities (Fig-
ure 1(c)), which on the face of it should benefit the
intercalation and improve ThT’s sheet sensing capabil-
ity. However, previously it was suggested that pheome-
lanin would be less likely than eumelanin to form flat
sheets due to steric hindrance,21. In addition there are
fewer cross-linking binding sites in pheomelanin’s build-
ing blocks than there are in eumelanin1 and this may also
limit sheet formation in pheomelanin. Nevertheless our
findings are consistent with sheet formation. Indeed the
use of fluorescence lifetime distribution analysis rather
than discrete component analysis may well shed light on
the relative degree of heterogeneity of both forms, but,
as we show later, the relative amplitude of discrete decay
components may also provide some useful information on
this.
L-DOPA, >98%, L-Cysteine, >97%, tyrosinase from
mushroom with 2687 enzymatic units per mg (u/mg) and
ThT were used as supplied by Sigma-Aldrich. Stock so-
lutions of each reactant were made by mixing each com-
pound with distilled water such that the final concentra-
tion became 3 mM for L-DOPA and cysteine, 1 mM for
ThT and 1500 u/ml for tyrosinase. The stock solution of
L-DOPA was sonicated for 5-10 mins to ensure the pow-
der had completely dissolved. The pH of the samples
was within the range of 6.4 and 7.0. Mixing the solu-
tions for measurement followed previous studies where a
concentration of 40 µM L-DOPA and 40 µM ThT was
used.19 Specifically, 125 µl of ThT was added to 3 ml
of distilled water, followed by 125 µl of melanin solu-
tion. The pheomelanin synthesis followed the protocol
of D’Ischia et al22 where concentrations of L-DOPA and
cysteine had a ratio of 1 mM:1 mM and the tyrosinase
concentration were diluted to 500 enzymatic units per ml
(u/ml) and 750 u/ml. For eumelanin samples, 40 µM of
L-DOPA and 40 µM ThT were mixed in distilled water
with a solution of ammonium hydroxide prepared via di-
lution of ammonium hydroxide (max 33% NH3) solution
(Sigma Aldrich) with distilled water. A HORIBA pH me-
ter (model D-51) was used to monitor the pH of 50 ml of
distilled water as the ammonium hydroxide solution was
added. The volume of ammonium hydroxide needed to
increase the pH to 10 was 10 µl. Prior to measurement,
the diluted samples were aspirated 3 times with a 1 ml
3 
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FIG. 2. (a) Change in fluorescence at 490 nm excited at 450
nm during pheomelanin synthesis with the addition of ThT
at 750u/ml and 500u/ml concentrations of tyrosinase. (b)
Rescaled pheomelanin + ThT at 750 u/ml tyrosinase curve
from (a), intrinsic fluorescence of pheomelanin under the same
conditions and the effect of subtracting the intrinsic fluores-
cence. The latter curve as illustrated was subtracted, the
anomalous decrease in fluorescence after ∼ 70 mins suggest-
ing ThT and pheomelanin are coupled rather than photophys-
ically isolated.
pipette to ensure adequate mixing of reactants and then
sealed with Parafilm®.
All spectral measurements were performed in 4 ml,
clear wall, UV grade, plastic cuvettes (Fisher Scientific).
Absorption measurements were obtained using a Perkin-
Elmer Lambda 25 spectrophotometer. The wavelength
range was 250 nm to 1100 nm with a scan speed of 960
nm/min. Empty cuvettes filled with distilled water were
used in a reference channel to correct for solvent ab-
sorption. Fluorescence spectra were measured using a
HORIBA Scientific FluoroMax 2 fluorimeter. Time se-
ries data were obtained with the excitation monochroma-
tor set to 450 nm and the emission monochromator set to
490 nm. The integration time and the measurement time
interval was 1 second. Optical bandwidths were fixed at
4 nm for both excitation and emission. The total num-
ber of data points was 7200, which equated to a 2 hour
measurement window. A 7x2 mm stir bar was set to keep
the solution mixed but avoid vortex formation.
Fluorescence lifetime measurement and reconvolution
analysis were performed on a DeltaFlex with DAS6 soft-
ware (HORIBA Jobin Yvon IBH, Glasgow). For excita-
tion, a NanoLED laser diode at 437 nm with a 1 MHz
repetition rate and < 200 ps pulse width, was used.23
The emission monochromator was set to 490 nm at a
bandwidth of 32 nm. A 450 nm long pass filter in the
emission path reduced Rayleigh scatter. The emission
polarizer was set to the magic angle (55o) with respect to
the excitation polarizer to eliminate polarization effects.
Scattering from dilute LUDOX® was used to record the
instrumental response function. Measurements were con-
cluded when the peak count reached 10,000.
ThT is a molecular rotor probe as its benzothiazole and
aminobenzene rings form a twisted intramolecular charge
transfer (TICT) state with a negligible fluorescence quan-
tum yield in low viscosity solvents (Figure 1(b)), the yield
increasing at higher viscosities.24 When pheomelanin is
formed in the presence of ThT and excited at 450 nm
a spectral peak emerges at 490 nm which mirrors pre-
vious studies of ThT and eumelanin.19 (The peak at ∼
530 nm being consistent with the water Raman peak).
Hence we chose 450 nm as an excitation wavelength and
490 nm as the fluorescence wavelength in order to best
monitor ThT fluorescence rather than pheomelanin fluo-
rescence. Figure 2(a) charts this growth in fluorescence
and Figures 2(b) and 1(b) together show that ThT dom-
inates the fluorescence when added to pheomelanin, the
latter having a quantum yield as low as 10-4 depending
on excitation wavelength.25 Interestingly, an initial drop
in fluorescence is evident in Figure 2(a). (Note there is
also a much smaller initial decrease in pheomelanin in-
trinsic fluorescence). A likely explanation of this is that
in the early stages the precursor structures of pheome-
lanin transfer their energy to ThT, which has a lower flu-
orescence quantum yield until bound within sheets, thus
effectively quenching their fluorescence. Eumelanin with
ThT shows similar behavior. Initially some collisional
quenching can occur but as the ThT loosely binds to the
pheomelanin precursors static quenching would be likely
to dominate due to ThT’s TICT state. Subsequent in-
crease in fluorescence suggests that ThT intramolecular
rotation eventually becomes constrained within sheets.
This conclusion holds even if ThT becomes polymerized
within pheomelanin as in this case its fluorescence would
be expected to be quenched just as pheomelanin’s intrin-
sic fluorescence is.
Ignoring any pheomelanin-ThT interaction, and sub-
tracting the pheomelanin intrinsic fluorescence in the
manner previously used for eumlanin,19 the apparent in-
crease in ThT fluorescence as pheomelanin is formed is
considerably less than that for eumelanin (Figure 2(b)),
implying on the face of it less evidence for ThT intercala-
tion in a sheet structure. The fall in fluorescence after ∼
70 mins might in itself suggest that any sheet structure is
unraveling but that seems unlikely. This brings into ques-
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FIG. 3. Fluorescence decay fitted parameters as a function of synthesis time for (a) ThT and pheomelanin, (b) ThT and
eumelanin, (c) pheomelanin and (d) eumelanin. For both melanins with ThT the early stages were best described by a
two-exponential model until sheet structures started to be formed and thenceforth the measured decays fitted best to a three-
exponential model. The intrinsic pheomelanin and eumelanin decay fitted to three-exponentials from the outset. Error bars of
3 std. dev. are shown for the decay time τ3 and its relative amplitude B3.
tion the validity, in this case, of treating pheomelanin
and ThT in isolation and subtracting the pheomelanin
fluorescence, thus providing evidence for electronic cou-
pling between ThT and pheomelanin rather than them
acting as isolated entities. Following the initial transient
decrease and up to 100 mins the original 750 u/ml fluo-
rescence growth curve shown in Figure 2(a) and the cor-
responding curve with pheomelanin intrinsic fluorescence
subtracted up to 70 mins, as shown in Figure 2(b), can
both be described by a similar sigmoidal function to that
for eumelanin19 i.e.
I(t) ∼ I(0) + α/{1 + exp[−k(t− t0)]} (1)
Where I(t) is the fluorescence intensity and I(0) is the
initial or background fluorescence intensity level. The pa-
rameter α is the fluorescence maximum above the back-
ground, k is the rate of melanin formation and t0 the
time where the fluorescence intensity has reached the half
maximum value. The fitted values are shown in Table I
along with the reduced chi-squared (χ2) and compared
with that previously reported for ThT and eumelanin.
There are similarities in the values found for both forms
TABLE I. Values for pheomelanin and ThT obtained from
fitting a sigmoidal function to the normalized fluorescence
growth curves of Figure 2 compared to those published pre-
viously for ThT and eumelanin.19
Sample I(0) α k (min−1) t0 (mins) χ
2
Pheo + ThT (750 u/ml) -0.20 1.128 0.061 31.1 0.99
(Pheo + ThT) - Pheo -0.0023 0.83 0.092 28.8 0.93
Eumelanin + ThT19 -0.062 1.19 0.17 48.6 -
of melanin with the presence of the enzyme tyrosinase
with pheomelanin reducing the time delay t0 for sheets
to be formed and the rate of sheet formation to half that
of eumelanin. The effect of subtracting pheomelanin in-
trinsic fluorescence is included in Table I for comparison
as it still displays evidence for sheet formation by fitting
to Eq.1.
Looking for further insight into the interactions be-
tween melanin and ThT we measured fluorescence decay
components of ThT in both pheomelanin and eumelanin
(Figure 3(a) and (b)). Prior to ∼ 20 mins both forms
5of melanin with ThT present offered no improvement in
reduced χ2 by fitting to more than 2-exponentials as the
decay is dominated by free ThT in water (τ1 ∼ 20 ps, rel-
ative amplitude > 97%). Beyond 20 mins 3-exponentials
consistently gave a better description for ThT in both
forms (χ2 ≤ 1.2 for ThT-pheomelanin). One component
(τ3), increasing in ThT-pheomelanin up to ∼ 5 ns and
in ThT-eumelanin up to ∼ 6 ns, is associated with the
fluorescence increase. Previous work has shown that for
ThT in Aβ and protein sheets the longest decay com-
ponent is ∼ 2 ns26,27 and the pure radiative decay time
in glycerol to be 3.4 ns.24 Hence the ThT decay compo-
nent we observe to increase up to ∼ 5 ns in pheomelanin
and ∼ 6 ns in eumelanin correlates with ∼ 5 ns com-
ponent for pheomelanin intrinsic fluorescence and ∼ 6
ns for eumelanin intrinsic fluorescence shown in Figures
3(c) and 3(d) respectively. This implies coupling between
the excited states of melanin and ThT bound in sheets.
The detailed nature of this interaction, and indeed en-
ergy transfer mechanisms, warrants further investigation
beyond the scope of this present work, though Dexter
exchange interaction, resonance energy transfer and exci-
ton diffusion are all possible. The slightly higher average
ThT-pheomelanin value for 〈τ3〉 (4.96 ns), in compari-
son to that for pheomelanin without ThT (4.72 ns), also
bears testimony to close coupling modifying the radiative
rates when ThT is intercalated within sheets. Moreover,
the constancy in decay components and relative abun-
dance of τ2 after ∼ 70 mins in both Figures 3(a) in the
presence of ThT, and Figure 3(c) without ThT, and the
relative increase in average τ2 value with ThT (〈τ2〉 =
0.86 to 1.26 ns), suggests that ThT also dominates this
component. Given the likely distribution of ThT loca-
tions within pheomelanin τ2 may well originate from sites
with less sheet structure. The increase in relative abun-
dance B3 of τ3 for ThT in eumelanin (∼ 12%) compared
to ThT in pheomelanin (∼ 6%) would be consistent with
increased sheet formation in eumelanin and indeed could
be a useful descriptor of the degree of heterogeneity.21
For ThT in both pheomelanin and eumelanin τ3 and B3
provide unequivocal evidence that it is not just melanin
intrinsic fluorescence which is being tracked. For example
in Figure 3 B3 for pheomelanin rises to ∼ 50% but is only
∼ 6% when ThT is added and in the case of eumelanin B3
remains fairly constant at ∼ 17% whereas in the presence
of ThT gradually increases to ∼ 6%. Methods of describ-
ing and discriminating between pheomelanin and eume-
lanin are clearly important in medical applications4–7 and
the fluorescence decay of a probe such as ThT, which we
describe here, potentially offers a simpler approach than
ultrafast methods such as two-photon excitation4–6 and
transient absorption.28
It is important to keep in mind that because pheome-
lanin is complex, incorporating numerous heterogenic
structures capable of excitation and emission, expo-
nential decay component analysis should be viewed as
an approximation. However, together the dominant
fluorescence intensity of ThT with pheomelanin shown
in Figures 1(b) and 2, and the trends in fluorescence
decay parameters in Figure 3, support interpretation in
terms of sheet formation.
See supplementary material for the fluorescence decay
data and associated tables of fitted parameters.
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